{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T23:50:10Z","timestamp":1655250610917},"reference-count":23,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2004]]},"DOI":"10.5551\/jat.11.293","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:32Z","timestamp":1308231932000},"page":"293-298","source":"Crossref","is-referenced-by-count":3,"title":["A Case of Marked Hyperlipoprotein(a)emia Associated with Nephrotic Syndrome and Advanced Atherosclerosis"],"prefix":"10.5551","volume":"11","author":[{"given":"Yoko","family":"Kuge","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kawanishi City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Nozaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kawanishi City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kawanishi City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kawanishi City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kawanishi City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kawanishi City General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"(1) McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, and Lawn RM: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature, 330: 132−137, 1987","DOI":"10.1038\/330132a0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"(2) Berg K, Dahlen G, and Frick MH: Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet, 6: 230−235, 1974","DOI":"10.1111\/j.1399-0004.1974.tb00657.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"(3) Murai A, Miyahara T, Fujimoto N, Matsuda M, and Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis, 59: 199−204, 1986","DOI":"10.1016\/0021-9150(86)90048-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"(4) Abe A, Yoshimura Y, Sekine T, Maeda S, Yamashita S, and Noma A: Fully mechanized latex immunoassay for serum lipoprotein (a). Clinica Chim Acta, 225: 105−113, 1994","DOI":"10.1016\/0009-8981(94)90038-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"(5) Abe A, Noma A, and Itakura H: Lipoprotein(a) phenotyping using a computerized micro scale and phenotype frequencies in a healthy Japanese population. Clin Chim Acta, 219: 149−157, 1993","DOI":"10.1016\/0009-8981(93)90206-J"},{"key":"6","doi-asserted-by":"crossref","unstructured":"(6) Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, and Seitz C: Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest, 80: 458−465, 1987","DOI":"10.1172\/JCI113093"},{"key":"7","doi-asserted-by":"crossref","unstructured":"(7) Keane WF and Kasiske BL: Hyperlipidemia in the nephrotic syndrome. N Engl J Med, 323: 603−604, 1990","DOI":"10.1056\/NEJM199008303230910"},{"key":"8","doi-asserted-by":"crossref","unstructured":"(8) Thiery J, Ivandic B, Bahlmann G, Walli AK, and Seidel D: Hyperlipoprotein(a)aemia in nephrotic syndrome. Eur J Clin Invest, 26: 316−321, 1996","DOI":"10.1046\/j.1365-2362.1996.132283.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"(9) De Sain-Van Der Velden MG, Reijngoud DJ, Kaysen GA, Gadellaa MM, Voorbij H, Stellaard F, Koomans HA, and Rabelink TJ: Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome. J Am Soc Nephrol, 9: 1474−1481, 1998.","DOI":"10.1681\/ASN.V981474"},{"key":"10","doi-asserted-by":"crossref","unstructured":"(10) Joven J, Simo JM, Vilella E, Camps J, Espinel E, and Villabona C: Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria. Clin Chem, 41: 908−913, 1995","DOI":"10.1093\/clinchem\/41.6.908"},{"key":"11","doi-asserted-by":"crossref","unstructured":"(11) Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, and Thillet J: Elevated lipoprotein (a) levels in primary nephrotic syndrome. Am J Kidney Dis, 22: 808−813, 1993","DOI":"10.1016\/S0272-6386(12)70339-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"(12) Utermann G: Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol, 10: 133−141, 1999","DOI":"10.1097\/00041433-199904000-00007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"(13) De Sain-Van Der Velden MG, Reijngoud DJ, Kaysen GA, Gadellaa MM, Voorbij H, Stellaard F, Koomans HA, and Rabelink TJ: Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome. J Am Soc Nephrol, 9: 1474−1481, 1998","DOI":"10.1681\/ASN.V981474"},{"key":"14","unstructured":"(14) Kaysen GA: Hyperlipidemia of the nephrotic syndrome. Kidney Int, 39: S8−S15, 1991"},{"key":"15","doi-asserted-by":"crossref","unstructured":"(15) Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto and AM Jr: Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation, 74: 758−765, 1986","DOI":"10.1161\/01.CIR.74.4.758"},{"key":"16","doi-asserted-by":"crossref","unstructured":"(16) Bambauer R, Schiel R, Keller HE, Klinkmann J, and Latza R: Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein (a) levels. Artif Organs, 20: 340−243, 1996","DOI":"10.1111\/j.1525-1594.1996.tb04456.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"(17) Bambauer R, Schiel R, Latzo R, and Klinkmann J: LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein (a) levels. Transfus Sci, 16: 375−381, 1995","DOI":"10.1016\/0955-3886(95)00048-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"(18) Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, and Qunici GB: Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis, 38: 51−61, 1981","DOI":"10.1016\/0021-9150(81)90103-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"(19) Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, and Seidel D: The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis, 62: 249−257,1986.","DOI":"10.1016\/0021-9150(86)90099-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"(20) Dahlen GH, Weinehall L, Stenlund H, Jansson JH, Hallmans G, Huhtasaari F, and Wall S: Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden. J Intern Med, 244(5): 425−430, 1998","DOI":"10.1046\/j.1365-2796.1998.00422.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"(21) Frick MH, Dahlen G, Berg K, Valle M, and Hekali P: Serum lipids in angiographically assessed coronary atherosclerosis. Chest, 73: 62−65, 1978","DOI":"10.1378\/chest.73.1.62"},{"key":"22","doi-asserted-by":"crossref","unstructured":"(22) Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Takemura T, Miki, S, Kuwahara T, Takamitsu Y, Tsubakihara Y, and the Kansai FGS LDL Apheresis Treatment (K-FLAT) Study Group: Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy. Nephron, 89: 408−415, 2001","DOI":"10.1159\/000046112"},{"key":"23","doi-asserted-by":"crossref","unstructured":"(23) Saito T, Sato H, Kudo K, Oikawa S, Shibata T, Hara Y, Yoshinaga K, and Sakaguchi H: Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis, 13: 148−153, 1989.","DOI":"10.1016\/S0272-6386(89)80134-9"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/11\/5\/11_5_293\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T09:47:59Z","timestamp":1637833679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/11\/5\/11_5_293\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.11.293","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004]]}}}